Safety of Parecoxib When Used For More Than 3 Days For The Management of Postoperative Pain

References

• American Society of Anesthesiologists Task Force on Acute Pain Management . Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management . Anesthesiology116 ( 2 ), 248 – 273 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Official ERAS website . www.erassociety.org/ .
   Google Scholar
• Kehlet H . Multimodal approach to control postoperative pathophysiology and rehabilitation . Br. J. Anaesth.78 ( 5 ), 606 – 617 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Kehlet H , WilmoreDW . Multimodal strategies to improve surgical outcome . Am. J. Surg.183 ( 6 ), 630 – 641 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Zhao SZ , ChungF , HannaDB , RaymundoAL , CheungRY , ChenC . Dose–response relationship between opioid use and adverse effects after ambulatory surgery . J. Pain Symptom Manage.28 ( 1 ), 35 – 46 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Wheeler M , OderdaGM , AshburnMA , LipmanAG . Adverse events associated with postoperative opioid analgesia: a systematic review . J. Pain3 ( 3 ), 159 – 180 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Dahan A , AartsL , SmithTW . Incidence, reversal, and prevention of opioid-induced respiratory depression . Anesthesiology112 ( 1 ), 226 – 238 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Pattinson KT . Opioids and the control of respiration . Br. J. Anaesth.100 ( 6 ), 747 – 758 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Alam A , GomesT , ZhengH , MamdaniMM , JuurlinkDN , BellCM . Long-term analgesic use after low-risk surgery: a retrospective cohort study . Arch. Intern. Med.172 ( 5 ), 425 – 430 ( 2012 ).
   PubMedGoogle Scholar
• Cheatle MD . Prescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safety . Pain Med.16 ( Suppl. 1 ), S3 – S8 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Harned M , SloanP . Safety concerns with long-term opioid use . Expert Opin. Drug Saf.15 ( 7 ), 955 – 962 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Ramneesh G , SheerinS , SurinderS , BirS . A prospective study of predictors for post laparotomy abdominal wound dehiscence . J. Clin. Diagn. Res.8 ( 1 ), 80 – 83 ( 2014 ).
   PubMedGoogle Scholar
• Williams KS . Postoperative nausea and vomiting . Surg. Clin. North Am.85 ( 6 ), 1229 – 1241 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• European Medical Agency . Summary of product characteristics . www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000381/WC500038843.pdf .
   Google Scholar
• Dynastat Australian Prescribing Information . www.pfizer.com.au/sites/g/files/g10005016/f/201311/PI_Dynastat_306.pdf .
   Google Scholar
• Lloyd R , DerryS , MooreRA , McquayHJ . Intravenous or intramuscular parecoxib for acute postoperative pain in adults . Cochrane Database Syst. Rev. ( 2 ), CD004771 ( 2009 ).
   Web of Science ®Google Scholar
• Schug SA . The role of COX-2 inhibitors in the treatment of postoperative pain . J. Cardiovasc. Pharmacol.47 ( Suppl. 1 ), S82 – S86 ( 2006 ).
   PubMedGoogle Scholar
• Schug SA , JoshiGP , CamuF , PanS , CheungR . Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data . Anesth. Analg.108 ( 1 ), 299 – 307 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Barton SF , LangelandFF , SnabesMCet al. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery . Anesthesiology97 ( 2 ), 306 – 314 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Bikhazi GB , SnabesMC , BajwaZHet al. A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy . Am. J. Obstet. Gynecol.191 ( 4 ), 1183 – 1191 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Nussmeier NA , WheltonAA , BrownMTet al. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery . Anesthesiology104 ( 3 ), 518 – 526 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Snabes MC , JakimiukAJ , KotarskiJ , KatzTK , BrownMT , VerburgKM . Parecoxib sodium administered over several days reduces pain after gynecologic surgery via laparotomy . J. Clin. Anesth.19 ( 6 ), 448 – 455 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Malan TP Jr , MarshG , HakkiSI , GrossmanE , TraylorL , HubbardRC . Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty . Anesthesiology98 ( 4 ), 950 – 956 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Viscusi ER , GimbelJS , HalderAM , SnabesM , BrownMT , VerburgKM . A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty . Anesth. Analg.107 ( 2 ), 652 – 660 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hubbard RC , NaumannTM , TraylorL , DhaddaS . Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia . Br. J. Anaesth.90 ( 2 ), 166 – 172 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bello AE , HoltRJ . Cardiovascular risk with non-steroidal anti-inflammatory drugs: clinical implications . Drug Saf.37 ( 11 ), 897 – 902 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sherve K , GerardCJ , NeherJO , St AnnaL . Cardiovascular effects of NSAIDs . Am. Fam. Physician90 ( 4 ), Online ( 2014 ).
   PubMedGoogle Scholar
• Murray MD , BraterDC . Renal toxicity of the nonsteroidal anti-inflammatory drugs . Annu. Rev. Pharmacol. Toxicol.33 , 435 – 465 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Weir MR . Renal effects of nonselective NSAIDs and coxibs . Cleve. Clin. J. Med.69 ( Suppl. 1 ), SI53 – SI58 ( 2002 ).
   PubMedGoogle Scholar
• Allison MC , HowatsonAG , TorranceCJ , LeeFD , RussellRI . Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs . N. Engl. J. Med.327 ( 11 ), 749 – 754 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Bjarnason I . Gastrointestinal safety of NSAIDs and over-the-counter analgesics . Int. J. Clin. Pract. Suppl.67 ( s178 ), 37 – 42 ( 2013 ).
   Google Scholar
• Leese PT , HubbardRC , KarimA , IsaksonPC , YuSS , GeisGS . Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial . J. Clin. Pharmacol.40 ( 2 ), 124 – 132 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Noveck RJ , LaurentA , KussM , TalwalkerS , HubbardRC . Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals . Clin. Drug Investig.21 ( 7 ), 465 – 476 ( 2001 ).
   Web of Science ®Google Scholar
• Rostom A , MuirK , DubéCet al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane collaboration systematic review . Clin. Gastroenterol. Hepatol.5 ( 7 ), 818 – 828 , 828.e815 ( 2007 ).
   PubMed Web of Science ®Google Scholar